Abstract:BACKGROUND:Protein kinase, membrane-associated tyrosine/threonine 1 (PKMYT1) contributes to the proliferative, migratory, invasive and colony-forming capabilities of oncocytes. Dysregulated expression of PKMYT1 is associated with numerous malignancies. However, at present, the functional role of PKMYT1 in osteosarcoma is still not clarified.OBJECTIVE:The present study, therefore, aimed to investigate the prognostic value of PKMYT1 in osteosarcoma, and to explore the underlying molecular mechanism(s).METHODS:To meet this end, the expression level of PKMYT1 in osteosarcoma was measured by immunohistochemical analysis. The prognostic value of PKMYT1 in osteosarcoma was analyzed on the basis of R2: Genomics Analysis and Visualization Platform. The functional role of PKMYT1 was subsequently investigated in MG63 cells by knocking down PKMYT1 expression via lentivirus encoding shRNA. MTT assay, scratch-wound and Transwell assays were then used to determine whether PKMYT1 fulfills a role in the proliferative and invasive capabilities of the MG63 cells. Subsequently, the role of PKMYT1 in the apoptosis of the cells was assessed using western blot and immunofluorescence analyses. Finally, to determine whether PKMYT1 exerts its role through the NF-κB pathway, fibroblast-stimulating lipopeptide-1 (FSL-1) was used as an NF-κB activator.RESULTS:Compared with normal tissues, osteosarcoma tissues showed a significantly increased level of PKMYT1 expression. The clinical survival analysis indicated that patients with high PKMYT1 expression were associated with lower probabilities of overall survival and metastasis-free survival compared with those with low PKMYT1 expression levels. Knockdown of PKMYT1 inhibited the migratory and invasive capabilities of the MG63 cells, and also facilitated their apoptosis. Moreover, the knockdown of PKMYT1 restrained the NF-κB pathway in MG63 cells, whereas activating the NF- κB pathway ameliorated the effects of silencing PKMYT1 on MG63 cells, suggesting that PKMYT1 functions via the NF-κB pathway in MG63 cells.CONCLUSION:Taken together, the results of the present study have shown that a high expression level of PKMYT1 is associated with poor prognosis of osteosarcoma, and that PKMYT1 is able to aggravate the malignant progression of MG63 cells via negatively regulating the NF-κB pathway, suggesting that PKMYT1 may be a potential molecular therapeutic target for the treatment of osteosarcoma.

Downregulation of MCT1 Inhibits Tumor Growth, Metastasis and Enhances Chemotherapeutic Efficacy in Osteosarcoma Through Regulation of the NF-κB Pathway.

microRNA-486 suppressed proliferation , migration and invasion of osteosarcoma cells via directly targeting SIRT 1

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response in Osteosarcoma

Inhibition of Macropinocytosis Enhances the Sensitivity of Osteosarcoma Cells to Benzethonium Chloride.

Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells

MicroRNA-455-3p Inhibits Osteosarcoma Progression Via HSF1 Downregulation

Anticancer Effect of (S)-Crizotinib on Osteosarcoma Cells by Targeting MTH1 and Activating Reactive Oxygen Species.

KNTC1 knockdown inhibits the proliferation and migration of osteosarcoma cells by MCM2

The Downregulation of MiR-182 is Associated with the Growth and Invasion of Osteosarcoma Cells Through the Regulation of TIAM1 Expression

Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c‐Myc‐mediated BCAT1 downregulation

High Expression of PKMYT1 Predicts Poor Prognosis and Aggravates the Progression of Osteosarcoma Via the NF-κB Pathway in MG63 Cells.

Monocyte Chemoattractant Protein-1 promotes cancer cell migration via c-Raf/MAPK/AP-1 pathway and MMP-9 production in osteosarcoma

MUC1 Promotes Cancer Stemness and Predicts Poor Prognosis in Osteosarcoma.

Downregulation of Connective Tissue Growth Factor Reduces Migration and Invasiveness of Osteosarcoma Cells.

Monocyte Chemotactic Protein-1 Promotes the Proliferation and Invasion of Osteosarcoma Cells and Upregulates the Expression of Akt

Activation of dynamin-related protein 1 - dependent mitochondria fragmentation and suppression of osteosarcoma by cryptotanshinone

Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis

SDF-1/CXCR4 Axis Facilitates Myeloid-Derived Suppressor Cells Accumulation in Osteosarcoma Microenvironment and Blunts the Response to Anti-Pd-1 Therapy

Mta1 Downregulation Inhibits Malignant Potential in A Small Cell Lung Cancer Cell Line

Tetrahydrocurcumin Induces Mesenchymal-Epithelial Transition and Suppresses Angiogenesis by Targeting HIF-1α and Autophagy in Human Osteosarcoma.

C3AR1 Mrna As a Potential Therapeutic Target Associates with Clinical Outcomes and Tumor Microenvironment in Osteosarcoma